Navigation Links
immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio
Date:9/21/2010

mpany developing advanced therapeutic vaccines that are active against cancer, announced today that it has raised EUR53.8million in a Series C financing round. The new funds will allow the Company to finance the ongoing development of immatics' existing pipeline of advanced therapeutic cancer vaccine candidates. In particular, it allows the company to perform a Phase III pivotal trial of its lead product IMA901 which in data reported in June at ASCO, demonstrated the potential to confer an overall survival benefit in patients with advanced renal cell carcinoma (RCC).

The Series C round was supported by both existing and new investors. Approximately half of the funds came from dievini Hopp Biotech holding, Wellington Partners and other existing shareholders, the other half coming from new investors MIG-advised funds and AT Impf GmbH. Upon the completion of the round Dr. Matthias Kromayer from MIG AG will join the immatics board. dievini Hopp BioTech holding remains immatics' largest shareholder following this financing.

With the new funds, immatics will start a Phase III pivotal clinical trial with its lead cancer vaccine IMA901 later this year. IMA901 is a rationally designed cancer vaccine comprised of 10 different tumor-associated peptides (TUMAPs) that are frequently found to be over-expressed in the majority of patients suffering from renal cell carcinoma. The trial design builds on insights gained from the Phase II study and input from key opinion leaders and regulatory agencies. The trial will be a randomized, controlled study that will evaluate IMA901 in renal cell carcinoma patients in combination with standard of care against standard of care alone in a first-line setting. The primary end point of the trial will be overall survival and the first results are expected towards the end of 2013.

immatics will also continue the clinical development of IMA910, another therapeutic vaccine that is currently being evaluated in a Phase II clini
'/>"/>

SOURCE immatics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Dyadic International Raises Additional $1 Million to Complete $4 Million Convertible Note Offering
2. StatRad Raises the Bar With Fully Integrated Teleradiology Solution
3. HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing
4. AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides
5. Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
6. SynapDx Corporation Raises $9 Million in Series A Funding
7. NanoPowers Raises CHF 5 Million ($4.5 Million) in Series A Financing to Support Development of Breakthrough Urinary Incontinence Device
8. Curexo Technology Corporation Raises $13.2 Million
9. Cardinal Health Raises Quarterly Dividend By 11 Percent
10. IMPLANET Raises Additional EUR 8 Million (USD 11 Million) to Fuel Deployment
11. Intercept Pharmaceuticals Raises $25 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... FRANKFURT , Deutschland, 4. März 2015 ... führender Anbieter von medizinischen Bildmanagementlösungen für Unternehmen, ... Ernennung von Randolph Sternberg zum Director of ... Director of Operations weiter aus. ... Randolph Sternberg ist für den ...
(Date:3/4/2015)... , March 4, 2015  ECR Booth #317/Expo C ... is showcasing a full spectrum of X-ray imaging solutions ... reduce costs, and enable greater patient throughput for manufacturers ... systems.  These solutions are on display at the Annual ... Vienna, Austria this week.   ...
(Date:3/4/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... upcoming 27 th Annual ROTH Conference, taking place ...  Dr. Michael Berelowitz , Chairman of ... corporate overview on March 10, 2015.   ...
Breaking Medicine Technology:TeraRecon baut seine Präsenz in EMEA aus 2TeraRecon baut seine Präsenz in EMEA aus 3Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3
... 2012 Ranbaxy Laboratories Inc. (RLI), a wholly owned ... that the U.S. Food and Drug Administration (FDA) has ... acne medication isotretinoin, for the treatment of severe recalcitrant ... firm, Cipher Pharmaceuticals Inc., RLI is expected to launch ...
... Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a ... it has received approval for a key patent by ... and Compositions for Oral Administration of Exenatide," covers oral ... now consists of three issued patents and 34 patents ...
Cached Medicine Technology:Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA 2Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand 2Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand 3
(Date:3/4/2015)... March 04, 2015 Alliance Healthcare Foundation ... wellness for those in need in San Diego and ... organizations through its Mission Support Grants program with awards ... organizations applied for AHF’s Mission Support Grants program. Grant ... board of trustees and program committee, as well as ...
(Date:3/4/2015)... State officials have awarded $82,500 to ... Public Health at Georgia State University, to support the ... Georgia’s Division of Family and Children Services (DFCS) as ... Center. , The 1-800-CHILDREN Helpline is a top ... referral services that promote the wellbeing of children while ...
(Date:3/4/2015)... Estates, CA (PRWEB) March 04, 2015 ... clever dialogue and lyrical music, will be performed by ... Rolling Hills Estates, CA, this March 6-22, 2015, on ... Arts Center at Peninsula High School (27118 Silver ... available one hour before the program or may be ...
(Date:3/4/2015)... March 04, 2015 The report ... client survey, marketing channels, industry development trend and ... the industry, including spices definitions, applications and industry ... market analysis are provided with a focus on ... market. A comparison between the international and Chinese ...
(Date:3/4/2015)... Information Innovators Inc . (Triple-i) is ... joined the company as Chief Technology Officer. Mr. Dvorak ... the company, including customer-centric strategies and initiatives, and promoting ... experience as a technology executive and visionary. Prior to ... FBI including oversight of enterprise data management, analytic software ...
Breaking Medicine News(10 mins):Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3
... active antiretroviral treatment (HAART) needs to be careful// ... Belgium. ,Highly active antiretroviral treatment can dramatically ... expectancy. This is especially helpful for patients with ... to have a full commitment to the antiviral ...
... neck cancer who are undergoing radiation// therapy can now ... ,Oropharyngeal candidiasis is a fungal infection in the ... also called thrush. The symptoms of the disease are ... when removed leaves a bleeding surface. This is a ...
... often had complained of a sudden increase in weight, especially ... this sudden influx of weight often results in obesity that ... rise in type 2 diabetes cases, cardiovascular diseases and other ... may be due to a drop in the estrogen levels ...
... had affected a total of 423 cases in Angola,// which ... the form of a vaccine. ,A virus causes Marburg ... Ebola hemorrhagic fever. The disease is a rare condition but ... symptoms begin with severe headaches and feeling of severe unwell. ...
... intake of vitamin B may be at less risk from ... of alcohol along with vitamin B may have even reduced ... happens when there is growth of abnormal or malignant cells ... was done by Swedish and American researchers, said that inadequate ...
... an injury to the knee. This may lead to inflammations ... identified a way to find out how much loss of ... in order to find out whether the injury may be ... considered to be a risk factor for arthritis, it was ...
Cached Medicine News:
... CELL-DYN are assayed linearity control kits that ... verify patient reportable range of three- and ... the linear performance of the analyzer. CVA ... ranges appropriate for each instrument model and ...
The technology in the LATITUDE system allows your doctor to get the same data from your device whether you are at home or in your doctor's office. This information transfer happens automatically....
... Proprietary EX.P.R.T. Release Technology essentially ... stent shortening,, Unique anatomically designed tapered ... carotid bifurcation,, 0.014 Rapid Exchange catheter ... and flexible atraumatic tip,, Radiopaque marker ...
... Para 5X is a whole blood hematology ... 60C+, 80 and 120, and the Coulter ... offers a unique white cell differential, positioning ... algorithms on the systems. The product offers ...
Medicine Products: